°
Newark

Latest News - #R-Pharm

Yaroslavl region was included into number of leaders of the Central Federal district on the index of industrial production

Yaroslavl oblast entered the top five leaders in the Central Federal district in index of industrial production which following the results of the first half made up 106.1%, which was 9.6% higher than the national average, said the Governor of the region Dmitry Mironov.

"The index of industrial production in the Yaroslavl region in the first half of the year compared to the same period last year made up 106.1%. This is 9.6% higher than the national average. We are in fifth place in the Central Federal district and on the 16th in the Russian Federation", - Mironov wrote on his page on the social network Facebook.

Russia responded to the accusations of London in an attempt to steal information about the vaccine

The head of the Russian direct investment Fund Kirill Dmitriev has denied the charges of London in an attempt to steal information about the development of a vaccine against coronavirus.

Earlier in the British cyber security centre said that over the years, hackers have carried out attacks on various organizations that participated in the creation of the drug from COVID-19. In London believe that the perpetrators "almost certainly" relate to the Russian intelligence service.

Drug "Cornavin" was sent to the Russian hospital

The drug from COVID-19 "Coronaves" sent to the Russian hospital, said RIA Novosti in the press service of the producer "R-Pharm".

"7374 packaging marked drug "Coronaves" came into circulation with the Yaroslavl plant "R-Pharm", - told in the company, adding that the drugs sent to the Russian hospital.

"R-Pharm" will direct "Karanvir" in the regions upon receipt of registration

The drug from COVID-19 "Coronaves" will be sent to the hospitals of Moscow, St.-Petersburg, Yaroslavl and other regions after receiving a registration certificate, said RIA Novosti in the pharmaceutical companies "R-Pharm".

The third Russian drug from COVID-19 international non-proprietary name favipiravir received the approval of the Ministry of health. Trade name of the drug is "Cornavin" producer company "R-farm", to information in the state register of medicines. The first drug on the basis of favipiravir was approved in late may, this "Aviewer" production RDIF and "Chimera". The second "Replevin" company "Promomed" in June. All drugs have a temporary registration until January 1, 2021.

Pharmaceutical manufacturer urged not to delay the introduction of labelling of medicines

Novosibirsk pharmaceutical manufacturer Renewal ("PFC Update") in an open letter urged the government not to transfer planned for July 1 start of mandatory labeling of drugs, it will harm the market and discreditied earlier decisions, according to the company.

From 1 July 2020 in Russia should be prohibited the circulation of drugs without digital codes. The sale of unmarked medicines received into circulation until July 1, 2020, will be allowed until the expiration of their shelf life. Meanwhile, on Thursday it became known that the Ministry of health of the Russian Federation jointly with the health Ministry and the Ministry are working on proposals to postpone the introduction of mandatory labelling of medicines. This follows from the document of the Ministry of health sent to the state Duma government hour. The decision is motivated by the fact that "the subjects of circulation of medicines" due to the complex epidemiological situation will not be able to prepare for the introduction of labeling.